
CaroGen
CaroGen develops vaccine candidates targeting hepatitis B and C, and other viral agents.
Employees
Enterprise value
$600—900k
Authorizing premium user...
CaroGen develops vaccine candidates targeting hepatitis B and C, and other viral agents.